Coronavirus: Commission concludes exploratory talks with Valneva to secure a new potential vaccine

(Credit: Unsplash)

This article is brought to you in association with the European Commission.

Today, the European Commission concluded exploratory talks with the pharmaceutical company Valneva with a view to purchasing its potential vaccine against COVID-19. The envisaged contract with Valneva would provide for the possibility for all EU Member States to purchase together 30 million doses, and they could further purchase up to 30 million more doses.

Today’s finalisation of exploratory talks with Valneva come in addition to an already secured broad portfolio of vaccines to be produced in Europe, including the contracts already signed with AstraZeneca, Sanofi-GSK, Janssen Pharmaceutica NV, BioNtech-Pfizer, CureVac, and Moderna and exploratory talks concluded with Novavax. This diversified vaccines portfolio will ensure Europe is well prepared for vaccination, once the vaccines have been proven to be safe and effective, as is already the case for BioNTech/Pfizer and Moderna, recently authorised in the EU. Member States are able to donate vaccines to lower and middle-income countries or to re-direct it to other European countries.

President of the European Commission, Ursula von der Leyen, said: “The continuing COVID-19 pandemic in Europe and around the globe makes it more important than ever that all Member States have access to the broadest possible portfolio of vaccines to help protect people in Europe and beyond. Today’s step toward reaching an agreement with Valneva further complements the EU’s vaccines portfolio and demonstrates the Commission’s commitment to find a lasting solution to the pandemic.”

Stella Kyriakides, Commissioner for Health and Food Safety, said: “With this eighth vaccine, we are adding to our already broad and diversified range of vaccines in our portfolio. By doing this, we can maximise our chances of making sure that all citizens can have access to safe and effective of vaccinations by the end of 2021. All Member States have now started their vaccination campaigns and will start receiving an increasing number of doses in order to cover all their needs during this year.”

Valneva is a European biotechnology company developing an inactivated virus vaccine. This is a traditional vaccine technology, used for 60-70 years, with established methods and a high level of safety. Most of the influenza vaccines and many childhood vaccines use this technology. This is currently the only inactivated vaccine candidate in clinical trials against COVID-19 in Europe.

The Commission, with the support of EU Member States, has taken a decision to support this vaccine based on a sound scientific assessment, the technology used, the company’s experience in vaccine development and its production capacity to supply all EU Member States.


The European Commission presented on 17 June a European strategy to accelerate the development, manufacturing and deployment of effective and safe vaccines against COVID-19. In return for the right to buy a specified number of vaccine doses in a given timeframe, the Commission finances part of the upfront costs faced by vaccines producers in the form of Advance Purchase Agreements. Funding provided is considered as a down-payment on the vaccines that will actually be purchased by Member States.

Since the high cost and high failure rate make investing in a COVID-19 vaccine a high-risk decision for vaccine developers, these agreements will therefore allow investments to be made that otherwise might not happen.

Once vaccines have been proven to be safe and effective and have been granted market authorisation by the European Medicines Agency, they need to be quickly distributed and deployed across Europe. On 15 October, the Commission set out the key steps that Member States need to take to be fully prepared, which includes the development of national vaccination strategies. The Commission is putting in place a common reporting framework and a platform to monitor the effectiveness of national vaccine strategies and has adopted further actions  to reinforce preparedness and response measures across the EU and a strategy on staying safe from COVID-19 during winter offering further support to Member States in the deployment of vaccines.

The Commission is also committed to ensuring that everyone who needs a vaccine gets it, anywhere in the world and not only at home. No one will be safe until everyone is safe. This is why it has raised almost €16 billion since 4 May 2020 under the Coronavirus Global Response, the global action for universal access to tests, treatments and vaccines against coronavirus and for the global recovery and has confirmed its interest to participate in the COVAX Facility for equitable access to affordable COVID-19 vaccines everywhere. As part of a Team Europe effort, the Commission announced is contributing with €400 million in guarantees an additional €100 million in grant funding to support COVAX Facility and its objectives in the context of the Coronavirus Global Response. This €500 million from the EU budget combined with contributions from EU Member States and the EIB will be a key contribution for the COVAX Facility to ensure over one billion vaccine doses will be made available to people in low- and middle-income countries by the end of 2021.

the sting Milestone

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

The EU Parliament unanimously rejects Commission’s ideas about ‘seeds’

Eurasian Union begins: the giant modelled on the EU is Moscow’s biggest challenge

Here’s how we get businesses to harmonize on climate change

The EU Diplomacy in North Korea promotes peace or war?

EU Commission: Banking and energy conglomerates don’t threaten competition!

Why does the whole world want Britain to stay in the EU?

A European Discovers China: 3 First Impressions

‘Highly explosive’ escalation of conflict and displacement across Syria’s Idlib, says top UN official

Women’s rights and how medical students can act as aides of progressive change

France pushes UK to stay and Germany to pay

Global response to poverty and environmental goals ‘not ambitious enough’

Is your smart home as safe as you think?

UN standing with Zimbabwe, Malawi, Mozambique as Southern Africa death toll from deadly cyclone mounts

Sex education in Schools conducted by medical students

Digital Finance Package: Commission sets out new, ambitious approach to encourage responsible innovation to benefit consumers and businesses

93 million children with disabilities ‘among the most likely to be left behind’: UN rights chief

Africa’s Sahel must be a top priority for UN peacebuilding efforts, says commission

5 things you probably didn’t know about global health

Antitrust: Commission imposes interim measures on Broadcom in TV and modem chipset markets

Hot air behind your cold fridge? Why the future of cooling must be sustainable

TTIP wins Merkel’s endorsement ahead of 2016 tough deadline

New ECB boss quizzed for the first time by Economic Affairs Committee

These are the world’s best universities

Ecocraft: take gaming to another level by greening Minecraft

How to bring precision medicine into the doctor’s office

Parliament’s proposal to reinforce flagship programmes is worth 39 billion euros

Dare to be vulnerable, and three other lessons in leadership

Youth Forum calls on Parliament to ease entry into Europe for young people

‘Negative developments’ undermining two-State solution in Middle East

In Afghanistan, attacks against schools have tripled in one year

German political spillovers: ECB’s Draghi resists first attacks by AfD

Will Qualcomm avoid Broadcom’s hostile takeover post the 1 bn euro EU antitrust fine?

Re-educating the angry brain amidst COVID-19

Humanitarian visas to avoid refugees’ deaths

MEPs agree on new rules to tax digital companies’ revenues

Thai cave boys spared thundershowers, highlighting extreme climate disruption: UN weather agency

Who cares more about taxpayers? The US by being harsh on major banks or the EU still caressing them?

‘Vaccines are safe’ and save lives, UNICEF declares, launching new #VaccinesWork campaign

Mental Health Policy, a significant driver for growth

Precision medicine should be accessible to all

Wars have rules: 5 things the UN humanitarian chief wants countries to tackle so human suffering in conflict can be minimized

Security Council calls for dialogue in Haiti

The world’s economy is only 9% circular. We must be bolder about saving resources

On European immigration: Europe’s Missing Citizens

Putin becomes the ‘perfect enemy” for the West

Saving the whales is more important than planting trees to stop climate change. This is why

Supercomputing could solve the world’s problems, and create many more

What did we learn from COP25?

Has the EU economy truly revived from the financial crisis?

A Union that strives for more: the first 100 days

25 years after population conference, women still face challenges to ‘well-being and human rights’, says UN chief

Eurozone in trouble after Nicosia’s ‘no’

European Commission pledges additional €30 million in immediate support for Lebanon

Europe fit for the Digital Age: Commission proposes new rules for digital platforms

Checks, fines, crisis reserve: MEPs vote on EU farm policy reform

We have a chance to build the gender-equal workplaces of the future. Here’s how

MEPs demand end to EU arms exports to Saudi Arabia

Here’s what travelling could be like after COVID-19

Finland has just published everyone’s taxes on ‘National Jealousy Day’

Fair completion rules and the law of gravity don’t apply to banks

More Stings?


Speak your Mind Here

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s